Patents by Inventor Oskar ANDERSSON

Oskar ANDERSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD40 binding protein, bispecific conjugate thereof and method of treating cancer
    Patent number: 12630643
    Abstract: Provided is a binding protein that binds CD40 and is an agonist thereof. In a particular embodiment the invention provides an agonistic anti-CD40 antibody. Also provided are bispecific conjugates comprising the binding protein, and complexes comprising the bispecific conjugates non-covalently bound to a tag construct comprising an antigen, for antigen delivery to immune cells. Medical uses of the binding proteins, conjugates and complexes of the invention are also provided.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: May 19, 2026
    Assignee: STRIKE PHARMA AB
    Inventors: Sara Mangsbo, Helena Persson Lotsholm, Oskar Andersson
  • CD40 BINDING PROTEIN
    Publication number: 20230167185
    Abstract: Provided is a binding protein that binds CD40 and is an agonist thereof. In a particular embodiment the invention provides an agonistic anti-CD40 antibody. Also provided are bispecific conjugates comprising the binding protein, and complexes comprising the bispecific conjugates non-covalently bound to a tag construct comprising an antigen, for antigen delivery to immune cells. Medical uses of the binding proteins, conjugates and complexes of the invention are also provided.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 1, 2023
    Inventors: Sara MANGSBO, Helena PERSSON LOTSHOLM, Oskar ANDERSSON